Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium

Clinical Infectious Diseases

Volumn 57, Issue 8, 2013, Pages 1114-1128

  Venkatesan, A ^a   Tunkel, A R ^b   Bloch, K C ^c,d   Lauring, A S ^e   Sejvar, J ^f   Bitnun, A ^g   Stahl, J P ^h   Mailles, A ⁱ   Drebot, M ^j   Rupprecht, C E ^k   Yoder, J ^f   Cope, J R ^f   Wilson, M R ^c,l   Whitley, R J ^m,n,o,p   Sullivan, J ^q   Granerod, J ^r   Jones, C ^q,s   Eastwood, K ^t   Ward, K N ^r,u   Durrheim, D N ^v,w   Solbrig, M V ^x   Guo Dong, L ^y   Glaser, C A ^z   Sheriff, Heather ^c   Brown, David ^c   Farnon, Eileen ^c   Messenger, Sharon ^c   Paterson, Beverley ^c   Soldatos, Ariane ^c   Roy, Sharon ^c   Visvesvara, Govinda ^c   Beach, Michael ^c   Nasci, Roger ^c   Pertowski, Carol ^c   Schmid, Scott ^c   Rascoe, Lisa ^c   Montgomery, Joel ^c   Tong, Suxiang ^c   Breiman, Robert ^c   Franka, Richard ^c   Keuhnert, Matt ^c   Angulo, Fred ^c   Cherry, James ^c   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c Department of Medicine ^*

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ French Institute for Public Health Surveillance   (France)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^k Erasmus Forum A434   (United States)

^l BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m University of Alabama at Birmingham   (United States)

ⁿ University of Alabama at Birmingham   (United States)

^o University of Alabama at Birmingham   (United States)

^p University of Alabama at Birmingham   (United States)

^q UNIVERSITY OF SYDNEY   (Australia)

^r PUBLIC HEALTH ENGLAND   (United Kingdom)

^s Sydney Emerging Infectious Diseases and Biosecurity Institute   (Australia)

^t HUNTER NEW ENGLAND POPULATION HEALTH   (Australia)

^u UNIVERSITY COLLEGE LONDON   (United Kingdom)

^v NEWCASTLE UNIVERSITY   (United Kingdom)

^w HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^x UNIVERSITY OF MANITOBA   (Canada)

^y CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^z Division of Communicable Disease Control   (United States)

more..

Author keywords

autoimmune; encephalitis; guidelines; host genetics; viral

Indexed keywords

ACANTHAMOEBA; ALGORITHM; ARTICLE; BALAMUTHIA MANDRILLARIS; BARTONELLA HENSELAE; BEHAVIOR CHANGE; CEREBELLAR ATAXIA; COGNITIVE DEFECT; CONFUSION; CONSENSUS; DISEASE SURVEILLANCE; DISORIENTATION; ENCEPHALITIS; ENTEROVIRUS; EPSTEIN BARR VIRUS; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; MYCOPLASMA PNEUMONIAE; NAEGLERIA FOWLERI; NONHUMAN; OROFACIAL DYSKINESIA; PARANEOPLASTIC NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES; RABIES VIRUS; RESEARCH PRIORITY; SEIZURE; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VARICELLA ZOSTER VIRUS; WEST NILE FLAVIVIRUS;

AUTOIMMUNE; ENCEPHALITIS; GUIDELINES; HOST GENETICS; VIRAL;

ADULT; ALGORITHMS; CHILD; CONSENSUS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; ENCEPHALITIS; HUMANS;

EID: 84884920102     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit458     Document Type: Article

References (90)

1. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303-27. (Pubitemid 352013512)
2. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10:835-44.
3. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994- 1995. Clin Infect Dis 1998; 26:398-409. (Pubitemid 28083954)
4. Ball R, Halsey N, Braun MM, et al. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System. J Clin Epidemiol 2002; 55:819-24.
5. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565-77. (Pubitemid 44901899)
6. Sejvar JJ, Kohl KS, Bilynsky R, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25:5771-92. (Pubitemid 47049772)
7. Mailles A, Stahl JP. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis 2009; 49:1838-47.
8. Noah DL, Bresee JS, Gorensek MJ, et al. Cluster of five children with acute encephalopathy associated with cat-scratch disease in south Florida. Pediatr Infect Dis J 1995; 14:866-9.
9. Armengol CE, Hendley JO. Cat-scratch disease encephalopathy: a cause of status epilepticus in school-aged children. J Pediatr 1999; 134:635-8. (Pubitemid 30180605)
10. Easley RB, Cooperstock MS, Tobias JD. Cat-scratch disease causing status epilepticus in children. South Med J 1999; 92:73-6. (Pubitemid 29048823)
11. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002; 35:512-7.
12. Newland JG, Romero JR, Varman M, et al. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis 2003; 36:e87-95.
13. Weitkamp JH, Spring MD, Brogan T, Moses H, Bloch KC, Wright PF. Influenza A virus-associated acute necrotizing encephalopathy in the United States. Pediatr Infect Dis J 2004; 23:259-63. (Pubitemid 38332655)
14. van Zeijl JH, Bakkers J, Wilbrink B, Melchers WJ, Mullaart RA, Galama JM. Influenza-associated encephalopathy: no evidence for neuroinvasion by influenza virus nor for reactivation of human herpesvirus 6 or Clin Infect Dis 2005; 40:483-5. (Pubitemid 40216521)
15. Bloch KC, Glaser C. Diagnostic approaches for patients with suspected encephalitis. Curr Infect Dis Rep 2007; 9:315-22. (Pubitemid 47162241)
16. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice- Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63-74.
17. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54:899-904.
18. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002; 34:1154-7. (Pubitemid 34289692)
19. Mook-Kanamori B, van de Beek D, Wijdicks EF. Herpes simplex encephalitis with normal initial cerebrospinal fluid examination. J Am Geriatr Soc 2009; 57:1514-5.
20. Jakob NJ, Lenhard T, Schnitzler P, et al. Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med 2012; 40:1304-8.
21. Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007; 119:e399-407. (Pubitemid 46397737)
22. Puchhammer-Stöckl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 1991; 29:1513-6.
23. Steiner I, Budka H, Chaudhuri A, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005; 12:331-43. (Pubitemid 40524172)
24. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010; 17:999-1009.
25. Kneen R, Michael BD, Menson E, et al. Management of suspected viral encephalitis in children-Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect 2012; 64:449-77.
26. Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults-Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012; 64:347-73.
27. de Ory F, Avellón A, Echevarría JE, et al. Viral infections of the central nervous system in Spain: A prospective study. J Med Virol 2013; 85:554-62.
28. Roos KL. Lumbar puncture. Semin Neurol 2003; 23:105-14. (Pubitemid 36857715)
29. Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn) 2012; 18:366-83.
30. Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012; 83: 638-45.
31. De Tiège X, Héron B, Lebon P, Ponsot G, Rozenberg F. Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin Infect Dis 2003; 36:1335-9. (Pubitemid 36629946)
32. Klapper PE, Cleator GM. European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis. Clin Microbiol Infect 1998; 4:178-80. (Pubitemid 28204103)
33. Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LEGilden DH. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995; 37:784-90.
34. Gregoire SM, van Pesch V, Goffette S, Peeters A, Sindic CJ. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry 2006; 77: 938-42. (Pubitemid 44174078)
35. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, group scai. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 2012; 18: 808-19.
36. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8:731-40.
37. Pérez-Vélez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: A diagnostic challenge. Clin Infect Dis 2007; 45:950-7. (Pubitemid 47580341)
38. Han J, Ma XJ, Wan JF, et al. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot- Mouth Disease after recovery. BMC Infect Dis 2010; 10:178.
39. Doja A, Bitnun A, Jones EL, et al. Pediatric Epstein-Barr Virus- Associated Encephalitis: 10-Year Review. J Child Neurol 2006; 21: 385-91.
40. Tyler KL. Emerging viral infections of the central nervous system: part 1 Arch Neurol 2009; 66:939-48.
41. Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45:1298-304. (Pubitemid 46626501)
42. Agut H. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J Clin Virol 2011; 52:164-71.
43. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000; 38:4066-71. (Pubitemid 32233206)
44. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection. J Clin Microbiol 2000; 38: 2232-9. (Pubitemid 30414344)
45. Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60:286-300. (Pubitemid 44520233)
46. Kapoor H, Signs K, Somsel P, Downes FP, Clark PA, Massey JP. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol 2004; 31:289-91. (Pubitemid 39371062)
47. Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005; 43:4316-20. (Pubitemid 41298207)
48. Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 2001; 32:1674-84. (Pubitemid 32536804)
49. Domenech C, Leveque N, Lina B, Najioullah F, Floret D. Role of Mycoplasma pneumoniae in pediatric encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:91-4.
50. Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005; 43:2277-85. (Pubitemid 40656241)
51. Bitnun A, Richardson SE. Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease? Curr Infect Dis Rep 2010; 12:282-90.
52. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133(Pt 6):1655-67.
53. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-8.
54. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-65.
55. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012; 72:902-11.
56. Graus F, Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol 2012; 25:795-801.
57. Chapman SJ, Hill AV. Human genetic susceptibility to infectious disease. Nat Rev Genet 2012; 13:175-88.
58. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-10. (Pubitemid 32763048)
59. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A2009; 106:19096-101.
60. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 2010; 42:30-5.
61. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9:356-69. (Pubitemid 351556063)
62. Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358:568-79.
63. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
64. Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol 2011; 1:487-96.
65. Hollidge BS, González-Scarano F, Soldan SS. Arboviral encephalitides: transmission, emergence, and pathogenesis. J Neuroimmune Pharmacol 2010; 5:428-42.
66. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85:328-45.
67. Cleton N, Koopmans M, Reimerink J, Godeke GJ, Reusken C. Come fly with me: review of clinically important arboviruses for global travelers. J Clin Virol 2012; 55:191-203.
68. Heinz FX, Stiasny K, Holzmann H, et al. Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis 2013; 19:69-76.
69. Centers for Disease Control and Prevention. West Nile virus disease and other arboviral diseases-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:510-4.
70. Arnold C.West Nile virus bites back. Lancet Neurol 2012; 11:1023-4.
71. Barzon L, Pacenti M, Franchin E, et al. Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill 2012; 17:20260.
72. Petersen LR, Fischer M. Unpredictable and difficult to control-the adolescence ofWest Nile virus. N Engl J Med 2012; 367:1281-4.
73. Public Health Agency of Canada: West Nile Virus MONITOR. http://www.phac-aspc.gc.ca/wnv-vwn/mon-hmnsurv-eng.php Accessed 27 June 2013.
74. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504-7.
75. Haddow AD, Odoi A. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007. PLoS One 2009; 4:e6145.
76. Centers for Disease Control and Prevention. Human Jamestown canyon virus infection-Montana, 2009. MMWR Morb Mortal Wkly Rep. 2011; 60:652-5.
77. Suraweera W, Morris SK, Kumar R, et al. Deaths from symptomatically identifiable furious rabies in India: a nationally representative mortality survey. PLoS Negl Trop Dis 2012; 6:e1847.
78. Rupprecht CE, Turmelle A, Kuzmin IV. A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol 2011; 1:662-70.
79. Kuzmin IV, Shi M, Orciari LA, et al. Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009. PLoS Pathog 2012; 8:e1002786.
80. Feder HM, Petersen BW, Robertson KL, Rupprecht CE. Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts. Curr Infect Dis Rep 2012; 14:408-22.
81. Gilbert AT, Petersen BW, Recuenco S, et al. Evidence of rabies virus exposure among humans in the Peruvian Amazon. Am J Trop Med Hyg 2012; 87:206-15.
82. National Association of State Public Health Veterinarians Ic. Compendium of animal rabies prevention and control, 2011. MMWR Recomm Rep 2011; 60(RR-6):1-17.
83. Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010; 59(RR-2):1-9.
84. Wilde H, Wacharapluesadee S, Hemachudha T. Currently approved postexposure rabies prophylaxis regimens. Travel Med Infect Dis 2012; 10: 162-3.
85. Lembo T, Prevention PFR. The blueprint for rabies prevention and control: a novel operational toolkit for rabies elimination. PLoS Negl Trop Dis 2012; 6:e1388.
86. Wu X, Smith TG, Rupprecht CE. From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 2011; 10:1597-608.
87. Jackson BR, Kucerova Z, Aguirre G, et al. Serologic survey of exposure following fatal Balamuthia madrillaris infection-Southern Arizona, 2010. 2012. Available at: http://www.cdc.gov/EIS/downloads/2012.EIS. Conference.pdf.
88. Schuster FL, Yagi S, Gavali S, et al. Under the radar: Balamuthia amoebic encephalitis. Clin Infect Dis 2009; 48:879-87.
89. Prevention CfDCa. Notes from the field: transplant-transmitted Balamuthia mandrillaris-Arizona, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1182.
90. Centers for Disease C, Prevention. Balamuthia mandrillaris transmitted through organ transplantation-Mississippi, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1165-70.